Welcome to Oncology Newswatch's case report exploration. This interactive case report will engage your experience and knowledge about details of a given case. Along the way, we will provide details and at the end, we will share the patient's outcome.

News

Multiple prognostic tools help risk stratify older patients with multiple myeloma and predict treatment-specific survival, according to data that will be presented at the 22nd Congress of the European Hematology Association (June 22-25, 2017; Madrid, Spain).

-----

Related Content

Read More

Adding a targeting agent to standard of care carfilzomib, lenalidomide, and dexamethasone (KRd) for multiple myeloma is a safe and efficacious alternative to autologous stem cell transplantation (ASCT) with KRd, according to research presented at the 2017 ASCO Annual Meeting (June2-6, 2017; Chicago, IL).

-----

Related Content

Read More

Survivors of Hodgkin lymphoma with a family history of cancer have a 1.3-fold higher risk of developing a second cancer, according to research published in the Journal of Clinical Oncology (May 2017;35[14]:1584-1590).

-----

Related Content

Read More

Subscribe to Multiple Myeloma